CA21914-6 - 0x000000000000375F

Study Number: CA21914
Group Number: 6
Study Requirement: Healthy Normal Male and Female
Stipend: $1,875.00

Study Criteria:

  • Age: 18 - 55
  • BMI: 18.5 - 30
  • Weight Restriction: minimum weight 0 lbs

Study Information:

  • Indication: This investigational medication is being developed to treat a disorder in which too much growth hormone is produced.
  • Route of Administration: Oral
  • Blood Draws: 23

Study Schedule:

  • Schedule Type: Short Term
  • Study Length: One - 5 Night Stay & 3 Returns

Screening Dates:

Event Day Event Date Site
Monday 7/30/2018 Phoenix

Doctor Exam Dates:

Event Day Event Date Site
Tuesday 8/7/2018 Phoenix

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Saturday 8/11/2018 11:00:00 AM Thursday 8/16/2018 8:30:00 AM 1 Phoenix
Return Friday 8/17/2018 7:30:00 AM Friday 8/17/2018 8:30:00 AM 1 Phoenix
Return Saturday 8/18/2018 7:30:00 AM Saturday 8/18/2018 8:30:00 AM 1 Phoenix
Return Sunday 8/19/2018 7:15:00 AM Sunday 8/19/2018 8:30:00 AM 1 Phoenix